Overall rank by patents
#28,336
of 49,997 tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: F16L (PIPES; Joints OR Fittings FOR PIPES; Supports FOR Pipes, Cables OR Protective TUBING; Means FOR Thermal Insulation IN General).
The verdict
According to USPTO PatentsView, Car-ber ranks #28,336 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R28336 · US Corporation #28,336 · 9 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Cancer Hospital, Chinese Academy OF Medical Sciences (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Car-ber Investments · this assignee
19 score
3D Lighting… · lowest
7 score
What this shows Car-ber's Innovation Score is 18.9/100 (5th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Car-ber Investments Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under F16L (PIPES; Joints OR Fittings FOR PIPES; Supports FOR Pipes, Cables OR Protective TUBING; Means FOR Thermal Insulation IN General). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2016. By volume, Car-ber sits between Cancer Hospital, Chinese Academy OF Medical Sciences and Cashstar, Inc..
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Cancer Hospital, Chinese Academy OF Medical Sciences
9 patents
Capartis AG
9 patents
Capella Therapeutics, Inc.
9 patents
Capital Normal University
9 patents
Carbicrete Inc.
9 patents
Carbon Free Holdings LLC
9 patents
Carfoldio Ltd.
9 patents
Cashstar, Inc.
9 patents
Car-ber Investments Inc.
9 patents
What this shows Car-ber holds 9 patents at rank #28,328, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #28,328 in granted patent volume.
Other assignees with the most granted patents in Car-ber's primary technology class.
Car-ber's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
19 5th percentile higher than 5% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 22.2% |
| 2016 | 1 | 11.1% |
| 2017 | 3 | 33.3% |
| 2018 | 1 | 11.1% |
| 2019 | 2 | 22.2% |
Top 5 of 5 technology areas
Overall rank by patents
#28,336
of 49,997 tracked assignees
18.9 out of 100
What to do with this data
Car-ber Investments Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.